Order
2030-63-9
N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropyliaino)phenazin-2-amine (Clofazimine)
Order
5965-55-9
2,2-dimethyl-5-[4-(1-methylimidazol-2-yl)sulfanyl-3-nitrophenyl]-1,3,5,6-tetrahydrobenzo[a]phenanthridin-4-one
Order
5965-97-9
2-[(4-oxo-5,6,7,8-tetrahydro-3h-[1]benzothiolo[2,3-d]pyrimidin-2-yl)sulfanyl]-n-prop-2-enylacetamide
Order
133140-70-2
[1,1'-Biphenyl]-2-carboxylic acid,4'-[[2-butyl-6-[[(cyclohexylamino)carbonyl]pentylamino]-1H-benzimidazol-1-yl]methyl]-, 1,1-dimethylethyl ester
Order
130112-10-6
L-Lysine,L-leucyl-L-tryptophylglycyl-L-alanyl-L-seryl-L-a-aspartyl-L-seryl-L-asparaginyl-L-valyl-L-tyrosyl-L-a-aspartyl-L-leucyl-L-leucyl-
1330180-60-3,1301214-63-0,1301214-73-2,133140-70-2,5965-55-9,60573-74-2 Supplier | KINGPHARM.GROUP
CMO CDMO service. KINGPHARM.GROUP supply 1330180-60-3,1301214-63-0,1301214-73-2,133140-70-2,5965-55-9,60573-74-2 and related compounds.
5965-55-9
133140-70-2
60573-74-2
1301214-63-0
1330180-60-3
1301214-73-2